{"ok":true,"article":{"slug":"regeneron-wins-fda-approval-to-challenge-ipsen-for-rare-bone-disease-market-a2a80210","title":"Regeneron wins FDA approval to challenge Ipsen for rare bone disease market","url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOdmdFbkZQRkZaOTRudE9SZ1JDR2J2TUpQQWxNYy1BYm5CaE5WVVRGdzlqWFczTS1fQmExeC0xV2pzSXFLY3I4b2Y2T0p0ZDBiWmV1WGg2LXRGWGdXZ2xPV3VFenVURkx4eE9MVG1CQ2hRZHprb3VEbHYtY3ZLLWpLR2RzRi1NQi1iN1g1SjdROXg5V3p5eDVZbjFRUVRyc1AzcW5YMUNNUQ?oc=5&hl=en-US&gl=US&ceid=US:en","canonical":"https://www.aimode.news/article/regeneron-wins-fda-approval-to-challenge-ipsen-for-rare-bone-disease-market-a2a80210","sourceName":"BioSpace","summary":"Related coverage: Regeneron wins FDA approval to challenge Ipsen for rare bone disease market BioSpace","category":"Health","image":null,"lang":"en","publishedAt":"2026-08-20T12:38:31+00:00","createdAt":"2026-08-20T13:00:12.672824+00:00"}}